Condition: Hyposmia · Olfactory Dysfunction · Anosmia · Sponsor: Queen Mary University of London
Slow-SPEED UK is an 18-month randomised, double-blind feasibility trial evaluating the delivery, adherence, and acceptability of a digitally supported physical activity programme in community-dwelling adults aged 40 and over with objectively confirmed hyposmia (reduced sense of smell) and low baseline physical activity. Participants are randomly assigned 1:1 to either a full-dose activity-support programme (targeting a 100% increase in daily step count) or a very low-dose active control (targeting a 10% increase). Both arms are delivered via a smartphone application linked to a wearable activity monitor (Fitbit Charge 6), with personalised weekly goals expressed as relative percentages to maintain blinding. The study is not designed to test clinical efficacy.
This description comes directly from the study's public registry record.
Viktoria Azoidou, PhD, MSc, BSc · 0207 882 3850 · v.azoidou@qmul.ac.uk
Alastair J Noyce, BMedSci, MBBS, MSc, MRCP, PhD · 0207 882 3850 · a.noyce@qmul.ac.uk
Always discuss trial participation with your own doctor first.
| Viktoria Azoidou | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06600438